Target Price | $78.03 |
Price | $84.92 |
Deviation |
8.11%
register free of charge
|
Number of Estimates | 26 |
26 Analysts have issued a price target Albemarle 2026 .
The average Albemarle target price is $78.03.
This is
8.11%
register free of charge
$131.25
54.56%
register free of charge
$58.58
31.02%
register free of charge
|
|
A rating was issued by 32 analysts: 12 Analysts recommend Albemarle to buy, 16 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Albemarle stock has an average upside potential 2026 of
8.11%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 5.38 | 4.98 |
44.08% | 7.32% | |
EBITDA Margin | -0.76% | 19.40% |
108.18% | 2,665.14% | |
Net Margin | -24.47% | -3.90% |
249.59% | 84.06% |
28 Analysts have issued a sales forecast Albemarle 2025 . The average Albemarle sales estimate is
This results in the following potential growth metrics:
28 Analysts have issued an Albemarle EBITDA forecast 2025. The average Albemarle EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Albemarle Analysts have issued a net profit forecast 2025. The average Albemarle net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -11.20 | -1.65 |
183.83% | 85.27% | |
P/E | negative | |
EV/Sales | 2.37 |
29 Analysts have issued a Albemarle forecast for earnings per share. The average Albemarle EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Baird |
Locked
➜
Locked
|
Locked | Aug 29 2025 |
UBS |
Locked
➜
Locked
|
Locked | Aug 26 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 31 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Jul 30 2025 |
Analyst Rating | Date |
---|---|
Locked
Baird:
Locked
➜
Locked
|
Aug 29 2025 |
Locked
UBS:
Locked
➜
Locked
|
Aug 26 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 18 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 31 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Jul 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.